XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Reconciliation of common stock outstanding
The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the three months ended March 31, 2023 and the twelve months ended December 31, 2022:
THREE MONTHS ENDED MARCH 31, 2023TWELVE MONTHS ENDED DECEMBER 31, 2022
Balance, beginning of period380,589,894 150,457,433 
Issuance of common stock3,130 229,618,304 
Non-vested share-based awards, net of withheld shares 223,405 514,157 
Balance, end of period380,816,429 380,589,894 
Earnings (loss) per share
The following table sets forth the computation of basic and diluted earnings per common share for the three months ended March 31, 2023 and 2022.
THREE MONTHS ENDED MARCH 31,
Dollars in thousands, except per share data20232022
Weighted average common shares outstanding
Weighted average common shares outstanding380,796,773 150,834,888 
Non-vested shares(1,956,353)(1,871,858)
Weighted average common shares outstanding - basic378,840,420 148,963,030 
Weighted average common shares outstanding - basic378,840,420 148,963,030 
Dilutive effect of employee stock purchase plan— 88,234 
Weighted average common shares outstanding - diluted378,840,420 149,051,264 
Net (loss) income attributable to common stockholders$(87,125)$42,227 
Dividends paid on nonvested share-based awards(605)(605)
Net (loss) income applicable to common stockholders - basic$(87,730)$41,622 
Basic earnings per common share - net income$(0.23)$0.28 
Diluted earnings per common share - net income$(0.23)$0.28 
Summary of the activity under the incentive plan and restricted stock unit
A summary of the activity under the Company's share-based incentive plans for the three months ended March 31, 2023 and 2022 is included in the table below.
THREE MONTHS ENDED MARCH 31,
 20232022
Share-based awards, beginning of period1,795,128 1,562,028 
Granted282,540 415,184 
Vested(101,720)(24,365)
Forfeited(20,503)(1,296)
Share-based awards, end of period1,955,445 1,951,551 
The following is a summary of the RSU activity during the three months ended March 31, 2023:
 Restricted Stock UnitsWeighted Average Grant Date Fair Value
Non-vested, beginning of period294,932 $33.04 
Granted165,174 22.55 
Vested/Forfeited(17,606)33.04 
Probability adjustment of 2022 RSUs (79,250)31.68 
Non-vested, end of period363,250 $28.57 
Schedule of stock options, valuation assumptions
THREE MONTHS ENDED MARCH 31,
Volatility34.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.42 %
Stock price (per share)$20.21
THREE MONTHS ENDED MARCH 31,
Volatility34.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.42 %
Stock price (per share)$20.21
Summary of employee stock purchase plan activity A summary of the activity under the ESPP for the three months ended March 31, 2023 and 2022 is included in the table below.
THREE MONTHS ENDED MARCH 31,
 20232022
Outstanding and exercisable, beginning of period340,976 348,514 
Granted— 255,960 
Exercised(3,130)(10,553)
Forfeited(21,421)(25,486)
Expired(132,999)(140,633)
Outstanding and exercisable, end of period183,426 427,802 
Schedule of unrecognized compensation cost, nonvested awards
The following table represents expected amortization of the Company's non-vested shares issued as of March 31, 2023:
Dollars in millionsFUTURE AMORTIZATION
of non-vested shares
2023$10.5 
202412.5 
202510.8 
20268.1 
20272.4 
2028 and thereafter0.5 
Total$44.8